Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • News & Views
  • Published:

CLONAL HEMATOPOIESIS

Multi-omics on our multitudes

Nature Genetics volume 54, pages 1449–1450 (2022)Cite this article

Subjects

Clonal expansion of DNMT3A-mutant hematopoietic stem cells is a risk factor for myeloid malignancies and other morbidities. A new study uses multi-modal single-cell genomics to characterize the myeloid differentiation bias of DNMT3A-mutated clones, and finds preferential hypomethylation of binding motifs for key transcriptional regulators.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Fig. 1: Single-cell multi-omic analyses show how DNMT3A R882 mutations bias hematopoietic fate decisions.

References

  1. Liggett, L. A. & Sankaran, V. G. Cell 182, 1384–1400 (2020).

    Article  CAS  Google Scholar 

  2. Fabre, M. A. et al. Nature 606, 335–342 (2022).

    Article  CAS  Google Scholar 

  3. Koya, J. et al. Nat. Commun. 7, 10924 (2016).

    Article  CAS  Google Scholar 

  4. Challen, G. A. et al. Nat. Genet. 44, 23–31 (2011).

    Article  Google Scholar 

  5. Nam, A. S. et al. Nat. Genet. https://doi.org/.1038/s41588-022-01179-9 (2022).

  6. Nam, A. S. et al. Nature 571, 355–360 (2019).

    Article  CAS  Google Scholar 

  7. Ludwig, L. S. et al. Cell 176, 1325–1339.e22 (2019).

    Article  CAS  Google Scholar 

  8. Xu, J. et al. eLife https://doi.org/10.7554/eLife.45105.001 (2019).

    Article  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Division of Hematology/Oncology, Boston Children’s Hospital and Department of Pediatric Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA

    Richard A. Voit & Vijay G. Sankaran

  2. Broad Institute of MIT and Harvard, Cambridge, MA, USA

    Richard A. Voit & Vijay G. Sankaran

Authors
  1. Richard A. Voit
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Vijay G. Sankaran
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Vijay G. Sankaran.

Ethics declarations

Competing interests

V.G.S. serves as an advisor to and/or has equity in Branch Biosciences, Ensoma, Novartis, Forma and Cellarity, all unrelated to the present work. The authors have no other competing interests to declare.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Voit, R.A., Sankaran, V.G. Multi-omics on our multitudes. Nat Genet 54, 1449–1450 (2022). https://doi.org/10.1038/s41588-022-01175-z

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/s41588-022-01175-z

Search

Advanced search

Quick links

Nature Briefing: Cancer

Sign up for the Nature Briefing: Cancer newsletter — what matters in cancer research, free to your inbox weekly.

Get what matters in cancer research, free to your inbox weekly. Sign up for Nature Briefing: Cancer